SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ribi Immunochem (ribi) -- Ignore unavailable to you. Want to Upgrade?

To: tom jones who wrote (55)3/12/1998 1:35:00 PM
From: mike head  Respond to of 92
 
Interesting! Since the last post, RIBI is up about 35%, yet this thread is dead. Runup apparently in anticipation of Canadian approval of Melacine. pax et bonum, mch



To: tom jones who wrote (55)3/12/1998 1:35:00 PM
From: tom jones  Read Replies (2) | Respond to of 92
 
To all: Jim McCamant has removed Ribi from his Medical technology stock letter and has told all to sell. He was on KWHY-22 Los Angeles today. Didn't give reason other then it hasn't moved for many years and there are better biotech stocks to own. Hope he is wrong on this call, everybody is wrong sometime; I know.
Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News